New concepts in the therapeutic options of liver metastases from colorectal cancer

Journal of B.U.ON.

Volumn 12, Issue 4, 2007, Pages 445-452

  Andromanakos, N ^a   Filippou, Dimitrios ^b,c,f   Papadopoulos, V ^d   Kouraklis, G ^e   Christianakis, E ^c   Kostakis, A ^e  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c General Hospital of Piraeus Tzaneio   (Greece)

^d Xanthi General Hospital   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f NONE   (Greece)

Author keywords

Ablation; Colorectal cancer; Hepatic artery chemoembolization; Liver metastases; Portal embolization; Two stage hepatectomy

Indexed keywords

ALCOHOL; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTIFICIAL EMBOLISM; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CRYOABLATION; ELECTROLYSIS; HEPATIC ARTERY; HUMAN; IMMUNOTHERAPY; LASER COAGULATION; LIVER METASTASIS; LIVER RESECTION; PORTAL VEIN; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL RATE; SURVIVAL TIME; ULTRASOUND THERAPY;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE;

EID: 38349094786     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Zibari GB, Riche A, Zizzi HC et al. Surgical and nonsurgical management of primary and metastatic liver tumors. Am Surg 1998; 64: 211-221.
2. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
3. Delaunoit T, Alberts SR, Sargent DJ et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005; 16:425-429.
4. Imamura H, Shimada R, Kubota M et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999; 29:1099-1105.
5. Bloomston M, Binitie O, Fraiji E et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002; 68: 827-831.
6. Khatri VP, McGahan J. Non-resection approaches for colorectal metastases. Surg Clin North Am 2004; 84:587-606.
7. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat unresectable liver tumors. Ann Surg 2000; 232: 777-785.
8. Urata K, Kawasaki S: Liver transplantation for liver metastases of colorectal cancer. Nippon Geka Gakkai Zasshi 2001;102:409-411.
9. Adam R, Avisar E, Ariche A et al. Five year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal liver metastases. Ann Surg Oncol 2001;8:347-353.
10. Minagawa M, Makuuchi M, Totzilli G et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-499.
11. Tocchi A, Mazzoni G, Brozzetti S, Miccini M, Cassini D, Bettelli E. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis 2004; 19: 580-585.
12. Mayer-Kuckuk P, Banerjee D, Kemeny N, Fong Y, Bertino JR. Molecular therapies for colorectal cancer metastatic to the liver. Mol Ther 2002;5:492-500.
13. Adam R, Lucidi V, Bismuth H. Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am 2004; 84:659-671.
14. Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004; 84: 413-435.
15. Holt DR, Van Thiel D, Edelstein S, Brems JJ. Hepatic resections. Arch Surg 2000; 135: 1353-1358.
16. Fusai G, Davidon BR. Management of colorectal liver metastases. Colorectal Dis 2003; 5:2-23.
17. Hamazaki K, Yagi T, Inagaki M et al. Hepatectomy under extracorporeal circulation. Surgery 1995; 118:98-102.
18. Torzilli G, Makuuchi M. Tricks for ultrasound-guided resection of colorectal liver metastases. Hepatogastroenterology 2003; 50: 1-3.
19. Detry O, De Roover A, Coimbra C et al. Recent advances in liver surgery and transplantation. Rev Med Liege 2007; 62: 310-316.
20. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12:887-894.
21. Pawlik TM, Scoggins CR, Zorzi D et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722.
22. Finch MD, Crosbie JL, Currie E, Garden OJ. An 8-year experience of hepatic resection: indications and outcome. Br J Surg 1998; 85: 315-319.
23. Taylor M, Forster J, Lunger B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173:467-471.
24. Fukunaga K, Takada Y, Otsuka M, Todoroki T, Fukao K. Resection of localized recurrences after hepatectomy of colorectal cancer metastases. Hepatogastroenterology 2003; 50:1894-1897.
25. Taal BG, VanTinteren H, Zoetmulder FA. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 2001; 85: 1437-1443.
26. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-2048.
27. Bozzetti F, Bignami P, Baratti D. Surgical strategies in colorectal cancer metastatic to the liver. Tumori 2000; 86: 1-7.
28. Prieto J, Qian C, Sangro B, Melero I, Mazzolini G. Biologic therapy of liver tumors. Surg Clin North Am 2004; 84: 673-696.
29. Hebbar M. Chemotherapy in patients with resectable liver metastases from colorectal cancer. Curr Colorectal Cancer Rep 2005; 1:34-40.
30. Martin RC, Edward MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer. Am J Surg 2004; 188: 714-721.
31. Kenemy N, Huang Y, Cohen AM et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-2048.
32. Kenemy N, Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med 2005; 352:734-735.
33. Kenemy N, Adak S, Gray B et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 2002; 20:1499-1505.
34. Portier C, Rougier P, Milan C et al. Adjuvant systemic chemotherapy using 5-fluorouracil and folinic acid after resection of liver metastases from colorectal cancer origin. Proc Am Soc Clin Oncol 2002; 20: 528 (abstr).
35. Langer B, Bleiberg H, Labianca R et al. Fluorouracil plus L-leucovorin versus observation after potentially curative resection of liver or lung metastases from colorectal cancer. Proc Am Soc Clin Oncol 2002; 20: 592 (abstr).
36. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175.
37. Azoulay D, Castaing D, Smail A et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231:480-486.
38. Sallivan KL. Hepatic artery chemoembolization. Semin Oncol 2002; 29: 145-151.
39. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: Hepatic metastasis. Semin Surg Oncol 1996; 12:219-252.
40. Garrean S, Hering J, Helton WS, Espat NJ. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 2007; 194:79-88.
41. Kokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004; 84:643-657.
42. Harada T, Matsuo K, Inoue T. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996; 224:4-9.
43. Majno PE, Adam R, Bismuth H et al. Influence of preoperative transarterial Lipiodol chemoembolization in resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-703.
44. Leichman CG, Jacobson JR, Modiano M et al. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma. A Southwest Oncology Group pilot trial. Cancer 1999; 86:775-781.
45. Tellez C, Benson AB III, Lyster MT et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998; 82: 1250-1259.
46. Gruttadauria S, Luca A, Mandala L, Miraglia R, Gridelli B. Sequential preoperative ipsilateral portal and arterial embolization in patients with colorectal liver metastases. World J Surg 2006; 30: 576-578.
47. Kalmakhelidze LG, Mosidze BA, Megrelishvili GZ. Strategy of treatment of patients with colorectal cancer with hepatic metastases. Georgian Med News 2005; 129:19-22.
48. Zangos S, Mack MG, Straub R et al. Transarterial chemoembolization (TACE) of liver metastases. A palliative therapeutic approach. Radiologe 2001; 41: 84-90.
49. Ruan DT, Warren RS. Liver-directed therapies in colorectal cancer. Semin Oncol 2005; 32: 85-94.
50. Giovannini M. Percutaneous alcohol ablation for liver metastasis. Semin Oncol 2002; 2:192-195.
51. Mazziotti A, Grazi GL, Gardini A et al. An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg 1998; 4:271-275.
52. Tranberg KG. Percutaneous ablation of liver metastases. Best Pract Res Clin Gastroenterol 2004; 18:125-145.
53. Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003; 90:272-289.
54. Gillams AR, Lees WR. Survival after percutaneous image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43: 656-661.
55. Solbiati L. New applications of ultrasonography: interventional ultrasound. Eur J Radiol 1998; 27 (Suppl 2): 200S-206S.
56. Donckier V, VanLaethem JL, Ickx B, Van Gansbeke D, Goldman S, Gelin M. Local ablative treatments for liver metastases: the current situation. Acta Chir Belg 2003; 103: 452-457.
57. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89:276-284.
58. Beppu T, Doi K, Ishiko T, Hirota M, Egami H, Ogawa M. Efficacy of local ablation therapy for liver metastases from colorectal cancer - radiofrequency ablation and microwave coagulation therapy. Nippon Geka Gakkai Zasshi 200l;102: 390-397.
59. Cline HE, Hynynen K, Watkins RD et al. Focused system for MR imaging-guided tumor ablation. Radiology 1995; 194: 731-737.
60. Hill CR, ter Haar GR. Review article: high intensity focused ultrasound-potential for cancer treatment. Br J Radiol 1995; 68: 1296-1303.
61. Charnley RM, Doran J, Morris DL. Cryotherapy for liver metastases: a new approach. Br J Surg 1989; 76:1040-1041.
62. Mala T, Edwin B, Mathisen O et al. Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand J Gastroenterol 2004; 39: 571-578.
63. Wallace JR, Christians KK, Pitt HA, Quebbeman El. Cryotherapy extends the indications for treatment of colorectal liver metastases. Surgery 1999; 126: 766-772.
64. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228:201-208.
65. Malik U, Mohiuddin M. External-beam radiotherapy in the management of liver metastases. Semin Oncol 2002; 29:196-201.
66. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90 yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001; 5:294-302.
67. Martinez-Monge R, Nag S, Nieroda CA, Martin EW. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer 1999; 85: 1218-1225.
68. Berry DP, Dennisou AR, Ward R, Maddern GJ. Electrolytic ablation of colorectal liver metastases: 1-year histological patient follow-up. Dig Surg 2000; 17: 518-519.
69. Fosh BG, Finch JG, Lea M et al. Use of electrolysis as an adjunct to liver resection. Br J Surg 2002; 89:999-1002.
70. Togo S, Nagano Y, Masui H et al. Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer. Hepatogastroenterology 2005; 52: 913-919.
71. Adam R, Miller R, Pitombo M et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007; 16: 525-536.